IEX Stock Cash Flow Statements

IDEX Quarterly Cash Flow Statements Chart

Quarterly

Annual

Capital Expenditure

IDEX Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31

cash flows from operating activities
net income	131,100,000	95,400,000	123,200,000	118,900,000	141,200,000	121,300,000	108,300,000	209,000,000	138,500,000	139,800,000	130,000,000	178,700,000	138,100,000	139,900,000	118,735,000	115,714,000	102,179,000	112,672,000	101,068,000	103,848,000	70,864,000	101,998,000	96,850,000	105,194,000	113,209,000	110,268,000	98,137,000	106,352,000	107,126,000	98,958,000	93,746,000	83,768,000	83,844,000	75,899,000	57,347,000	69,873,000	75,759,000	68,130,000	67,763,000	79,505,000	69,585,000	65,954,000	61,620,000	71,441,000	71,777,000	74,548,000	67,555,000	63,799,000	62,561,000	61,300,000	-119,019,000	50,127,000	54,351,000	52,171,000	47,388,000
adjustments to reconcile net income to net cash flows from operating activities:
gain on sale of business				600,000							0																												0
asset impairments							0	300,000			400,000	16,800,000			-15,000	589,000	90,000	136,000	3,002,000				475,000
depreciation	19,000,000	18,400,000	18,600,000	17,400,000	16,300,000	16,200,000	15,300,000	14,700,000	14,400,000	12,800,000
amortization of intangible assets	32,000,000	31,500,000	32,100,000	26,500,000	23,900,000	24,600,000	24,300,000	23,800,000	23,200,000	23,600,000	19,800,000	17,000,000	16,900,000	15,300,000	15,719,000	16,168,000	13,523,000	10,990,000	10,721,000	11,091,000	10,488,000	9,544,000	9,586,000	9,794,000	8,954,000	8,999,000	8,990,000	8,838,000	9,796,000	10,871,000	10,521,000	11,488,000	12,104,000	11,789,000	13,074,000	12,818,000	12,256,000	10,890,000	11,086,000	11,203,000	10,207,000	9,930,000	10,235,000	11,020,000	11,069,000	10,863,000	11,045,000	11,213,000	11,178,000	10,891,000	10,751,000	10,433,000	10,349,000	9,952,000	10,058,000
share-based compensation expense	5,200,000	13,600,000	4,900,000	4,000,000	4,400,000	12,500,000	2,900,000	1,900,000	4,200,000	12,800,000	5,200,000	2,900,000	6,900,000	6,600,000	1,825,000	5,330,000	5,493,000	7,752,000	-1,780,000	7,490,000	6,935,000	6,730,000	7,049,000	6,207,000	6,853,000	7,560,000	4,940,000	6,562,000	5,600,000	7,652,000	6,262,000	5,745,000	6,239,000	6,159,000	5,001,000	3,722,000	5,161,000	6,442,000	5,313,000	2,933,000	4,920,000	6,882,000	4,272,000	4,482,000	5,651,000	6,312,000	3,529,000	3,975,000	3,877,000	5,612,000	1,940,000	2,986,000	3,515,000	4,661,000	2,321,000
deferred income taxes	700,000	900,000	-19,800,000	0	200,000	200,000	-12,900,000			-200,000	-18,700,000	400,000	-1,200,000	1,000,000	970,000	6,912,000	-14,543,000	561,000	6,915,000	-1,098,000	409,000	2,012,000	-4,903,000	843,000	7,658,000	3,027,000	-2,865,000	1,541,000	-980,000	-2,041,000	-35,630,000	-526,000	1,121,000	1,293,000	-22,188,000	1,211,000	719,000	2,950,000	-1,812,000	949,000	-476,000	1,000,000	-3,423,000	-4,699,000	277,000	-748,000	-4,340,000	1,248,000	53,000	-117,000	-41,850,000	1,084,000	3,463,000	74,000	-5,199,000
changes in
receivables – net	13,900,000	-12,300,000	-2,400,000	-2,600,000
inventories – net	-10,700,000	-34,900,000	39,200,000	-1,800,000
other current assets	-14,800,000	-7,000,000	4,500,000	7,600,000	-1,300,000	-10,900,000	-6,800,000	18,900,000	-7,500,000	-11,100,000	4,300,000	13,000,000	-5,100,000	-12,700,000	2,959,000	5,916,000	-3,225,000	3,350,000	17,379,000	-9,234,000	-4,154,000	-14,267,000	16,825,000	-6,804,000	-5,263,000	-7,119,000	17,527,000	-10,163,000	917,000	16,881,000	-4,918,000	-6,667,000	-15,016,000	6,570,000	-3,730,000	-1,043,000	-10,636,000	-6,597,000	14,000	-2,112,000	3,961,000	-4,591,000	-2,631,000	782,000	2,933,000	-6,285,000	-819,000	2,638,000	8,256,000	-3,513,000
trade accounts payable	-10,300,000	9,600,000	-6,400,000	15,000,000	-8,600,000	8,900,000	4,900,000	-12,300,000	-25,500,000	7,600,000	-8,000,000	-10,600,000	8,100,000	28,100,000	1,938,000	-1,607,000	2,527,000	20,042,000	14,198,000	-4,654,000	-20,988,000	14,146,000	-11,922,000	-14,469,000	-212,000	17,488,000	3,200,000	-9,852,000	-2,783,000	8,215,000	8,875,000	-2,788,000	1,281,000	5,188,000	16,769,000	-13,329,000	-9,818,000	6,451,000	1,174,000	-8,160,000	-2,699,000	6,857,000	-4,654,000	-11,103,000	-2,101,000	15,392,000	2,251,000	1,729,000	5,177,000	6,303,000	1,421,000	-1,584,000	-5,430,000	4,217,000	-7,290,000
deferred revenue	-2,400,000	8,800,000	-13,600,000	-4,600,000	-6,500,000	6,800,000	7,100,000	1,400,000	-6,000,000	10,200,000	-300,000	-26,000,000	-5,100,000	6,400,000	4,983,000	-685,000	4,413,000	11,089,000
accrued expenses	-4,500,000	-17,900,000	-8,100,000	21,400,000	-20,400,000	-1,500,000	-800,000	18,500,000	-27,600,000	-24,900,000	3,500,000	35,600,000	-6,200,000	-16,300,000	8,205,000	16,378,000	12,809,000	-11,592,000	-39,659,000	6,557,000	15,716,000	2,060,000	-13,864,000	16,380,000	-14,996,000	-24,606,000	4,115,000	21,164,000	6,142,000	-27,273,000	9,798,000	19,711,000	1,766,000	-11,565,000	-2,488,000	9,693,000	-6,034,000	-6,641,000	-18,739,000	17,953,000	-1,656,000	-14,230,000	4,691,000	24,921,000	-20,271,000	14,419,000	728,000	10,979,000	-960,000	1,043,000	-5,985,000	17,171,000	-4,079,000	2,837,000	-5,277,000
other – net	1,900,000	-400,000	300,000	2,900,000
net cash flows from operating activities	161,700,000	105,700,000	172,600,000	205,300,000	133,600,000	156,600,000	201,000,000	226,600,000	141,200,000	147,900,000	167,300,000	198,100,000	112,300,000	79,700,000	163,071,000	156,633,000	136,272,000	109,324,000	161,374,000	153,686,000	169,453,000	84,760,000	151,160,000	157,064,000	131,175,000	88,663,000	153,592,000	133,327,000	120,697,000	71,729,000	136,173,000	124,000,000	87,601,000	84,979,000	115,593,000	125,481,000	88,478,000	70,365,000	98,540,000	113,353,000	99,024,000	49,404,000	101,378,000	100,403,000	91,995,000	74,185,000	101,612,000	118,396,000	109,319,000	72,195,000	85,682,000	101,020,000	80,736,000	58,742,000	41,632,000
cash flows from investing activities
capital expenditures	-14,800,000	-14,300,000	-15,500,000	-13,700,000	-15,900,000	-20,000,000	-21,600,000
free cash flows
acquisition of business, net of cash acquired	0	4,200,000
proceeds from sale of business, net of cash remitted				-400,000							0
net cash flows from investing activities
cash flows from financing activities
borrowings under revolving credit facilities			0								170,400,000								0	0	0	150,000,000
payment of long-term borrowings			-25,000,000	0
payments under revolving credit facilities	-62,500,000	-30,200,000									-95,000,000								0	0							-156,000
cash dividends paid to shareholders	-53,500,000	-52,400,000	-52,300,000	-52,300,000	-52,200,000	-48,500,000	-48,400,000
(payments) proceeds from share issuances, net of shares withheld for taxes	300,000	-500,000
repurchases of common stock	-50,000,000	-50,000,000					-23,100,000	-100,000			-1,800,000	-35,900,000	-84,100,000	-26,300,000					0	0	-1,435,000	-108,907,000	0	0	-3,871,000	-50,797,000
net cash flows used in financing activities	-215,900,000	-133,300,000			-77,200,000	-41,000,000	-58,000,000	-194,700,000	-46,800,000	-45,200,000				-71,300,000				-40,424,000	-21,794,000			-7,802,000	-34,914,000	-74,043,000	-31,647,000	-86,981,000		-62,613,000											-59,952,000	-109,427,000	-106,087,000	-20,062,000	-46,983,000	-66,344,000				-97,541,000						-39,821,000
effect of exchange rate changes on cash and cash equivalents	26,500,000	10,900,000	-29,500,000	23,900,000	-3,700,000	-13,600,000	22,400,000	-12,800,000	-700,000	7,000,000	38,200,000	-33,400,000	-26,200,000	-6,200,000	-6,237,000	-10,187,000	5,299,000	-17,075,000	25,485,000	15,741,000	4,550,000	-6,600,000	14,776,000	-12,097,000	-449,000	482,000	-7,109,000	1,503,000	-13,814,000	1,974,000	8,693,000	15,355,000	11,193,000	4,159,000	-20,840,000	-2,889,000	-9,356,000	3,765,000	-4,011,000	-8,753,000	11,201,000	-33,858,000	-19,378,000	-22,337,000	934,000	-1,340,000	1,822,000	11,866,000	1,999,000	-9,237,000	3,062,000	5,915,000	-9,719,000	4,918,000	-6,688,000
net increase in cash and cash equivalents and restricted cash	-42,200,000	-26,700,000	-12,400,000
cash and cash equivalents and restricted cash at beginning of year	0	638,900,000
cash and cash equivalents and restricted cash at end of period	-42,200,000	612,200,000
supplemental cash flow information
cash paid for:
interest	21,100,000	15,600,000	21,900,000	2,500,000	20,600,000	2,400,000	20,300,000	5,400,000	21,000,000	4,100,000	18,200,000	400,000	18,100,000	400,000	18,161,000	682,000	16,674,000	483,000	18,737,000	326,000	15,813,000	276,000	17,851,000	550,000	17,959,000	323,000	17,780,000	324,000	17,868,000	355,000	17,412,000	354,000	18,292,000	760,000	18,806,000	1,242,000	16,054,000	965,000	15,433,000	773,000	16,505,000	791,000	16,040,000	171,000	16,269,000	85,000	16,001,000	874,000	16,012,000	545,000	10,029,000	1,952,000	18,121,000	2,537,000	11,503,000
income taxes – net	63,600,000	19,800,000		35,600,000
net cash flows used in investing activities		-10,000,000	-14,700,000			-20,000,000	-193,800,000	86,600,000	-147,400,000	-29,200,000	-692,800,000	35,700,000	-135,700,000	-124,400,000	-73,931,000	-14,917,000	-489,718,000	-119,534,000	-16,972,000			-133,720,000	-14,426,000	-98,128,000	-12,020,000	-12,441,000	-16,401,000	-39,201,000				-3,789,000				-267,606,000	-8,466,000	-230,115,000	-13,041,000	-186,000	-187,139,000	-10,125,000	-12,946,000	-9,991,000	-38,535,000	-10,788,000	-7,956,000	-7,405,000	-10,471,000	-42,330,000	-7,772,000	-44,515,000	-44,424,000	-8,555,000	-5,873,000
gain on sale of businesses – net
credit loss on note receivable from collaborative partner							0	0
acquisition of businesses, net of cash acquired			0				-201,500,000	0			-713,000,000	2,300,000	-120,200,000	-114,700,000	-1,794,000	0	-469,370,000	-106,236,000	-4,974,000	2,680,000	0	-120,839,000	0				0								0	-288,445,000	0	-221,556,000	-1,850,000	-19,830,000			-1,000	553,000			0	0	-2,201,000	-34,648,000	91,000	-34,820,000			2,435,000
proceeds from sale of businesses, net of cash remitted
purchase of marketable securities										-3,200,000
proceeds from sale of marketable securities			0
proceeds from issuance of long-term borrowings			0
debt issuance costs			-500,000												26,000	-15,000			-8,000	-575,000															0	-154,000			-41,000	-375,000															-3,018,000
proceeds from share issuances, net of shares withheld for taxes			6,200,000	2,600,000	200,000	7,700,000
net cash flows from financing activities			-140,800,000									-77,500,000				-39,412,000															-40,693,000	-50,636,000	-86,701,000	-99,391,000	-95,174,000	22,923,000	-67,613,000	186,412,000								-43,303,000				1,553,000	-22,611,000	-23,027,000			-19,273,000
cash and cash equivalents at beginning of year			0	0	0	534,300,000	0	0	0	430,200,000	0	0	0	855,400,000	49,000	0	0	1,025,851,000	0	0	0	632,581,000	0	0	0	466,407,000	0	0	0	375,950,000	0	0	0	235,964,000	0	0	0	328,018,000	0	0	0	509,137,000	0	0	0	439,629,000	0	0	0	318,864,000	0	0	0	230,259,000	0
cash and cash equivalents and restricted cash at end of year
income taxes - net						18,400,000																					17,595,000	34,948,000			26,223,000	27,920,000	44,821,000	5,888,000
purchases of marketable securities							-4,400,000	-5,500,000
net increase in cash and cash equivalents					84,400,000	82,000,000	-28,400,000	105,700,000	-53,700,000	80,500,000
cash and cash equivalents at end of period					84,400,000	616,300,000		105,700,000	-53,700,000	510,700,000		122,900,000	-175,400,000	733,200,000		92,117,000	-243,762,000	958,142,000		131,410,000	177,129,000	569,219,000		-27,204,000	87,059,000	456,130,000		33,016,000	45,778,000	412,973,000	72,659,000	84,930,000	2,266,000	216,095,000	-3,433,000	-122,091,000	3,043,000	358,445,000	21,536,000	-5,013,000	-183,001,000	494,496,000	22,071,000	1,731,000	26,952,000	458,383,000	39,824,000	25,316,000	33,444,000	341,045,000	58,361,000	39,393,000	-24,433,000	245,543,000	9,798,000
receivables - net						-12,200,000
inventories - net						-9,500,000
other - net						200,000	-1,000,000	2,700,000	2,500,000	1,100,000	-600,000	1,700,000	700,000	700,000	2,329,000	852,000	2,746,000	-3,627,000	-6,787,000	1,610,000	4,042,000	-1,897,000	958,000	2,474,000	-1,921,000	1,413,000	-8,172,000	-8,922,000				-1,164,000	-2,357,000	1,556,000
gain on sale of businesses - net																																			20,231,000
non-cash interest expense associated with forward starting swaps															25,000	0	2,416,000	859,000	868,000	869,000	2,739,000	1,545,000	1,590,000	1,566,000	1,583,000	1,588,000	1,606,000	1,610,000	1,627,000	1,632,000	1,651,000	1,681,000	1,646,000	1,677,000	1,707,000	1,701,000	1,719,000	1,724,000	1,743,000	1,748,000	1,767,000	1,772,000	1,791,000	1,795,000	1,817,000	1,820,000	1,843,000	1,847,000	1,868,000	1,872,000	1,894,000	1,898,000	1,920,000	1,925,000
termination of the u.s. pension plan, net of curtailment
payment of make-whole redemption premium															-41,000	0			0	0
other																																															-1,043,000	0			-154,000	52,000
cash and cash equivalents at end of year
receivables								17,400,000	-5,100,000	-700,000	-9,200,000	6,200,000	-19,700,000	-49,000,000	9,849,000	-12,992,000	32,000	-46,289,000	-12,418,000	-962,000	58,443,000	-24,190,000	24,409,000	12,106,000	7,225,000	-21,402,000	10,638,000	5,987,000	-9,228,000	-30,816,000	12,604,000	2,703,000	-11,052,000	-20,058,000	2,480,000	20,447,000	-3,358,000	-19,267,000	10,249,000	13,857,000	2,765,000	-18,039,000	10,284,000	-5,176,000	17,692,000	-33,910,000	3,241,000	16,110,000	1,687,000	-14,843,000	20,946,000	-809,000	8,060,000	-15,450,000	2,233,000
inventories								26,500,000	21,300,000	-23,300,000	27,200,000	-15,100,000	-34,300,000	-50,200,000	-18,028,000	-7,136,000	-13,397,000	-7,539,000	18,603,000	27,449,000	14,188,000	-23,717,000	13,665,000	4,020,000	-2,459,000	-18,548,000	4,872,000	108,000	-6,895,000	-21,116,000	5,629,000	-73,000	-2,035,000	-2,761,000	10,497,000	10,864,000	11,656,000	-270,000	11,031,000	3,999,000	742,000	-11,215,000	10,067,000	-2,304,000	-2,979,000	-12,605,000	6,444,000	-2,736,000	8,495,000	-3,115,000	14,612,000	8,400,000	999,000	-212,000	12,419,000
proceeds from issuance of 5.13% senior notes								0
payment of 3.20% senior notes								0
payments under term facility
net proceeds from stock option exercises
income taxes								44,200,000	82,200,000	20,700,000		42,600,000	71,500,000	15,400,000		21,178,000	54,359,000	18,322,000		44,487,000	11,289,000	10,492,000		28,624,000	41,791,000	13,911,000												9,516,000	42,396,000	33,879,000	25,927,000	10,411,000	30,670,000	29,824,000	43,966,000	17,835,000	25,496,000	22,716,000	18,443,000	7,002,000	25,550,000	30,532,000	22,229,000	9,292,000	19,338,000
adjustments to reconcile net income to net cash from operating activities:
gains on sales of assets									0	-200,000	-500,000
amortization of debt issuance expenses									400,000	400,000	500,000	400,000	400,000	400,000	346,000	393,000	595,000	366,000	365,000	375,000	633,000	343,000	342,000	344,000	334,000	335,000	334,000	334,000	332,000	332,000												434,000	433,000	431,000	430,000	429,000	428,000	426,000	424,000	425,000	576,000	472,000	268,000	369,000	316,000
purchases of property, plant and equipment									-21,600,000	-26,600,000	-20,000,000	-16,300,000	-15,600,000	-16,100,000	-27,213,000	-14,894,000	-15,984,000	-14,609,000	-12,107,000	-18,353,000	-8,323,000	-12,762,000	-14,139,000	-11,031,000	-12,867,000	-12,875,000	-16,233,000	-18,888,000	-10,959,000	-10,009,000
proceeds from disposal of fixed assets									400,000	900,000	1,900,000	400,000	100,000	6,500,000		8,000	31,000	211,000	57,000	116,000	2,073,000	41,000	5,000	177,000	151,000	629,000	152,000
dividends paid									-48,400,000	-45,500,000	-45,200,000	-45,300,000	-45,500,000	-41,400,000	-40,811,000	-41,047,000	-41,093,000	-38,149,000	-37,590,000	-37,750,000	-37,762,000	-38,736,000	-37,981,000	-37,944,000	-37,837,000	-33,446,000	-32,565,000	-32,997,000	-32,971,000	-28,945,000	-28,303,000	-28,297,000	-28,245,000	-26,327,000	-25,283,000	-25,937,000	-26,768,000	-24,662,000	-24,499,000	-24,763,000	-24,759,000	-22,151,000	-22,201,000	-22,332,000	-22,565,000	-18,628,000	-18,948,000	-18,536,000	-18,846,000	-16,575,000	-16,535,000	-16,660,000	-16,731,000	-14,161,000	-14,155,000
proceeds from stock option exercises									3,300,000	4,700,000	10,300,000	3,800,000	3,800,000	1,400,000	7,203,000	1,810,000	7,456,000	3,231,000	15,858,000	15,618,000	11,022,000	2,089,000	3,214,000	14,834,000	11,891,000	8,870,000	846,000	13,177,000	7,026,000	6,590,000	3,955,000	5,996,000	6,910,000	6,074,000	7,086,000	6,220,000	8,676,000	8,258,000	4,050,000	1,708,000	4,274,000	9,185,000	3,374,000	4,956,000	2,677,000	6,154,000	5,468,000	6,855,000	12,225,000	10,758,000	10,756,000	7,039,000	3,610,000	24,366,000	1,731,000
shares surrendered for tax withholding									-200,000	-4,400,000	-100,000	-200,000	0	-4,900,000	-420,000	-146,000	-74,000	-5,460,000	-10,000	-50,000	-29,000	-12,119,000	-13,000	-1,074,000	-30,000	-11,479,000	-295,000	-510,000	0	-10,750,000						-69,000	-113,000	-4,717,000
note receivable from collaborative partner															0	0
contributions received from joint venture partner
depreciation and amortization												12,300,000	12,500,000	12,200,000	14,319,000	10,801,000	10,926,000	10,554,000	10,800,000	10,260,000	10,138,000	10,453,000	9,944,000	9,729,000	10,210,000	9,660,000	9,324,000	9,768,000	9,774,000	10,183,000	9,889,000	9,792,000	9,730,000	8,903,000	9,494,000	9,374,000	9,919,000	9,067,000	9,060,000	9,174,000	8,880,000	8,580,000	8,390,000	8,589,000	8,347,000	8,394,000	8,594,000	8,566,000	8,899,000	8,948,000	9,623,000	9,112,000	8,854,000	9,238,000	9,211,000
termination of the u.s. pension plan																0
net decrease in cash												122,900,000	-175,400,000	-122,200,000				-67,709,000
gain on sale of assets													100,000	-2,700,000
significant non-cash activities:
debt acquired with acquisition of business																							0																												0	0			0
proceeds from issuance of 3.00% senior notes
proceeds from issuance of 2.625% senior notes																0
payment of 4.50% senior notes
payment of 4.20% senior notes
net increase in cash																92,117,000			148,093,000	131,410,000	177,129,000	-63,362,000	116,596,000	-27,204,000	87,059,000	-10,277,000	-25,360,000	33,016,000	45,778,000	37,023,000	72,659,000	84,930,000	2,266,000	-19,869,000	-3,433,000	-122,091,000	3,043,000	30,427,000	21,536,000	-5,013,000	-183,001,000	-14,641,000	22,071,000	1,731,000	26,952,000	18,754,000	39,824,000	25,316,000	33,444,000	22,181,000	58,361,000			15,284,000	9,798,000
proceeds from issuance of 3.0% senior notes																			0	0
payment of 4.5% senior notes																			0	0
payment of 4.2% senior notes
(gain) loss on sale of fixed assets - net
purchase of intellectual property																											0	0
payments under other long-term borrowings																			-44,000				-134,000
settlement of foreign exchange contracts																											0	0	-25,000	6,618,000	9,330,000	0
contingent consideration for acquisition																											0												0												0				293,000
capital expenditures for construction of new leased facility																											0	-355,000	6,170,000	5,801,000
net cash flows (used in) investing activities																														-10,193,000				-9,616,000
gain on sale of fixed assets - net
proceeds from sale of businesses, net of cash sold																																			6,535,000
pension settlement
proceeds from issuance of 3.20% senior notes
proceeds from issuance of 3.37% senior notes
purchases of common stock																											-123,272,000	-31,155,000
borrowings under revolving facilities																																0	20,000,000	13,000,000		180,133,000	5,000,000	275,391,000		33,279,000	295,342,000	55,000,000		50,995,000	34,005,000	20,014,000	10,027,000	1,000	22,987,000	5,438,000	24,976,000	37,993,000	22,001,000	9,509,000	90,000,000
other — net																														-1,749,000							755,000	-2,892,000	1,513,000	268,000	1,465,000	-710,000	-904,000	1,904,000	-1,892,000	-1,519,000	125,000	728,000	136,000	-172,000	5,560,000	2,569,000	-1,196,000	-8,922,000	14,537,000
net cash flows (used in) financing activities																														-26,487,000
income taxes — net																														10,942,000
excess tax benefit from share-based compensation																																							-915,000	-267,000	-863,000	-3,220,000	-915,000												-378,000
proceeds from fixed asset disposals
payment of 2.58% senior euro notes																																							0	0
unvested shares surrendered for tax withholding																															-325,000	-89,000	-167,000	-5,647,000					-42,000	-15,000	-95,000	-3,107,000	-49,000	-2,067,000	-222,000	-2,614,000	-121,000	-9,000	-37,000	-1,735,000	-14,000	-61,000	-147,000	-2,118,000	-170,000
amortization of debt issuance costs																																330,000	330,000	329,000		392,000	380,000	378,000		373,000
additions of property, plant and equipment																																-8,515,000	-9,377,000	-10,162,000		-11,590,000	-8,402,000	-8,650,000
proceeds from 3.20% senior notes																																				0
proceeds from 3.37% senior notes																																				0
payments under revolving facilities																																-15,395,000	-86,073,000	-80,224,000		-135,969,000	-245,209,000	-20,994,000		-55,348,000	-240,509,000	-77,000		-10,599,000	-22,564,000	-13,617,000		-35,185,000	-31,519,000	-305,000
purchase of common stock																																-12,851,000	-2,794,000	-7,005,000		-1,301,000	-9,107,000	-46,864,000	-33,050,000	-64,180,000	-51,460,000	-62,132,000	-73,851,000	-62,982,000	-45,523,000	-37,537,000	-30,231,000	-52,793,000	-51,364,000	-33,115,000	-14,389,000	-39,132,000	-25,859,000	-10,183,000
gain on sale of fixed assets																																																							0
adjustments to reconcile net income to net cash from operating activities
proceeds from sale of business																																							0
changes in:
cash purchases of property, plant and equipment																																										-10,077,000		-10,521,000	-12,490,000	-10,809,000		-7,318,000	-8,197,000	-7,625,000		-9,420,000	-10,173,000	-8,515,000	-7,191,000
excess tax benefit from share based compensation																																													-755,000	-2,925,000		-2,126,000	-2,332,000	-2,439,000		-839,000	-338,000	-2,118,000
borrowings under revolving facilities for acquisitions																																																0	0	34,648,000
excess tax benefit from stock-based compensation																																													755,000	2,925,000		2,126,000	2,332,000	2,439,000		839,000	338,000	2,118,000
forward starting interest rate contract settlement
borrowings under revolving facilities and credit facilities for acquisitions																																																			0	15,000,000
proceeds from issuance of 4.2% senior notes
payments under revolving facilities, credit facilities and term loan																																																			-28,430,000	-28,097,000	-54,289,000	-48,009,000	-443,171,000
borrowings under credit facilities
proceeds from issuance of 2.58% senior euro notes
proceeds from issuance of 4.5% senior notes
borrowings under credit facilities for acquisitions																																																							0
borrowings under credit facilities and term loan
issuance of unvested shares																																																							399,000
payments under credit facilities and term loan
loss on sale of fixed assets
goodwill impairment
forward starting interest rate contract
proceeds from fixed assets disposals
changes in restricted cash
payment of 6.875% senior notes
stock-based compensation expense
additions to property, plant and equipment
proceeds from issuance of senior notes
payments under credit facilities
cash flows from operating activities of continuing operations
income from discontinued operations
net cash flows from operating activities of continuing operations
cash flows from investing activities of continuing operations
proceeds from the sale of discontinued businesses
net cash flows used in investing activities of continuing operations
cash flows from financing activities of continuing operations
payment of senior notes
distributions to discontinued operations
net cash flows from financing activities of continuing operations
cash flows from discontinued operations
net cash from operating activities of discontinued operations
net cash from investing activities of discontinued operations
net cash from financing activities of discontinued operations
net cash flows used in discontinued operations
capital expenditures included in accounts payable
non-cash capital expenditures
change in restricted cash
loss (income) from discontinued operations
distributions from (to) discontinued operations
less-cash at end of period-discontinued operations
cash and cash equivalents at end of period-continuing operations
loss on sale of business
proceeds from sales of discontinued businesses
distributions for discontinued operations
net cash flows used in financing activities of continuing operations
less-cash, end of period-discontinued operations
net cash flows from discontinued operations

We provide you with 20 years of cash flow statements for IDEX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IDEX stock. Explore the full financial landscape of IDEX stock with our expertly curated income statements.

The information provided in this report about IDEX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.